可孚医疗 - Financials

可孚医疗 — Financial Statements

Annual Quarterly

5 10 All

Income Statement

Balance Sheet

Cash Flow

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
+Revenue	3.4B	3.0B	2.9B	3.0B	2.3B
Revenue Growth %	13.5%	4.5%	-4.1%	30.8%	--
Total Revenue	3.4B	3.0B	2.9B	3.0B	2.3B
Cost Of Revenue	1.6B	1.4B	1.6B	1.8B	1.3B
+Gross Profit	1.8B	1.5B	1.2B	1.2B	998.0M
Gross Margin %	53.1%	51.9%	43.3%	39.5%	43.8%
Total Operating Cost	3.1B	2.7B	2.6B	2.7B	1.9B
Selling Expenses	1.2B	973.0M	741.0M	619.0M	414.0M
Admin Expenses	173.0M	121.0M	111.0M	122.0M	56.9M
Rd Expenses	87.3M	96.4M	114.0M	118.0M	70.6M
Finance Expenses	-3.0M	-22.8M	-19.1M	-33.3M	-6.6M
+Operating Income	429.0M	373.0M	295.0M	368.0M	511.0M
Operating Margin %	12.7%	12.5%	10.3%	12.4%	22.5%
Non Operating Income	4.2M	6.3M	381,600	438,600	321,100
Non Operating Expenses	7.4M	7.6M	9.4M	34.5M	3.0M
Investment Income	15.8M	12.3M	47.7M	56.8M	-306,400
Fair Value Change Income	49.8M	9.4M	-1.6M	4.4M	6.3M
Asset Disposal Income	-1.4M	5.9M	4.6M	6.5M	139,300
Asset Impairment Loss	31.8M	33.8M	52.2M	46.3M	17.8M
Other Income	49.9M	32.2M	37.7M	31.2M	89.7M
Income Before Tax	426.0M	372.0M	286.0M	334.0M	508.0M
Income Tax	55.5M	59.7M	32.8M	32.4M	78.7M
+Net Income	370.0M	312.0M	253.0M	302.0M	430.0M
Net Margin %	10.9%	10.5%	8.9%	10.1%	18.9%
Net Income Attributable	372.0M	312.0M	254.0M	302.0M	429.0M
Minority Interest	-1.3M	592,600	-1.4M	336,200	729,300
Eps Basic	1.83	1.53	1.24	1.45	2.60
Eps Diluted	1.81	1.51	1.24	1.45	2.60

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
Cash And Equivalents	1.4B	1.3B	1.6B	1.4B	2.0B
Trading Financial Assets	1.0B	1.4B	851.0M	1.2B	1.5B
Accounts Receivable	405.0M	374.0M	474.0M	566.0M	346.0M
Notes Receivable	15.0M	55,100	632,700	--	--
Notes And Accounts Receivable	420.0M	374.0M	475.0M	566.0M	346.0M
Prepayments	148.0M	139.0M	131.0M	250.0M	67.0M
Inventory	675.0M	660.0M	635.0M	529.0M	481.0M
Total Current Assets	3.8B	3.9B	3.8B	4.2B	4.5B
Long Term Equity Investment	237.0M	61.4M	64.9M	5.3M	5.3M
Fixed Assets	1.5B	1.5B	1.5B	1.3B	214.0M
Fixed Assets Total	1.5B	1.5B	1.5B	1.3B	214.0M
Construction In Progress	139.0M	50.1M	49.3M	171.0M	508.0M
Construction In Progress Total	139.0M	50.1M	49.3M	171.0M	508.0M
Intangible Assets	278.0M	236.0M	241.0M	248.0M	202.0M
Long Term Deferred Expenses	46.3M	42.6M	50.9M	60.3M	47.8M
Total Non Current Assets	2.8B	2.5B	2.4B	2.2B	1.3B
Total Assets	6.6B	6.4B	6.2B	6.4B	5.8B
Short Term Borrowings	575.0M	549.0M	402.0M	281.0M	83.1M
Accounts Payable	559.0M	375.0M	397.0M	549.0M	310.0M
Advance Receipts	233,500	31.3M	14.0M	6.4M	8.4M
Contract Liabilities	29.1M	1.9M	2.8M	2.5M	1.6M
Total Current Liabilities	1.6B	1.4B	1.1B	1.2B	683.0M
Long Term Borrowings	--	125.0M	94.1M	30.0M	--
Total Non Current Liabilities	137.0M	259.0M	250.0M	190.0M	159.0M
Total Liabilities	1.7B	1.6B	1.3B	1.4B	842.0M
Paid In Capital	209.0M	209.0M	209.0M	208.0M	160.0M
Capital Reserve	3.9B	3.9B	3.9B	3.9B	3.9B
Surplus Reserve	105.0M	105.0M	94.8M	77.4M	60.5M
Retained Earnings	770.0M	764.0M	829.0M	838.0M	809.0M
Minority Equity	36.0M	5.8M	9.0M	12.6M	17.9M
Equity Attributable	4.9B	4.8B	4.9B	5.0B	4.9B
Total Equity	4.9B	4.8B	4.9B	5.0B	5.0B

Line Item	FY 2025Dec 31, 2025	FY 2024Dec 31, 2024	FY 2023Dec 31, 2023	FY 2022Dec 31, 2022	FY 2021Dec 31, 2021
Cash From Sales	3.5B	3.0B	2.9B	2.6B	2.2B
Tax Refunds Received	14.0M	13.4M	29.6M	16.0M	14.9M
Total Operating Cash Inflow	3.8B	3.2B	3.1B	2.8B	2.3B
Cash Paid For Goods	1.3B	1.3B	1.4B	1.7B	1.2B
Cash Paid To Employees	592.0M	548.0M	506.0M	436.0M	311.0M
Taxes Paid	260.0M	155.0M	230.0M	130.0M	180.0M
Total Operating Cash Outflow	3.1B	2.5B	2.7B	2.7B	2.1B
Operating Cash Flow	696.0M	663.0M	394.0M	98.9M	240.0M
Total Investing Cash Inflow	2.3B	941.0M	1.3B	1.8B	3.7M
Total Investing Cash Outflow	2.4B	1.7B	1.4B	2.4B	2.1B
Investing Cash Flow	-69.0M	-731.0M	-45.7M	-537.0M	-2.1B
Cash From Borrowings	1.2B	750.0M	543.0M	612.0M	142.0M
Dividends And Interest Paid	372.0M	374.0M	250.0M	265.0M	4.3M
Debt Repayments	1.2B	471.0M	365.0M	394.0M	344.0M
Total Financing Cash Inflow	1.2B	807.0M	615.0M	628.0M	3.7B
Total Financing Cash Outflow	1.7B	1.0B	892.0M	757.0M	413.0M
Financing Cash Flow	-469.0M	-234.0M	-278.0M	-129.0M	3.3B
Net Change In Cash	155.0M	-301.0M	70.7M	-567.0M	1.4B
Ending Cash Balance	1.3B	1.1B	1.4B	1.4B	1.9B
Capex	178.0M	120.0M	373.0M	640.0M	513.0M